Overview
Gene (OMIM No.) |
|
Function of gene/protein |
|
Clinical phenotype (OMIM phenotype no.) | |
Inheritance |
|
Ocular features |
|
Systemic features | Manitoba oculotrichoanal syndrome
|
Key investigations |
|
Molecular diagnosis | Next generation sequencing
|
Management | Ocular
|
Therapies under research |
|
Further information |
Additional information
The Manitoba oculotrichoanal syndrome was first described by Marles et al in the Oji-Cree Manitoba Indian population residing in an isolated part of northeastern Manitoba, Canada. Subsequent reports of patients from outside this region have been reported since.
References
- Kiyozumi D, Sugimoto N, Sekiguchi K. Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects. Proc Natl Acad Sci. 2006;103(32):11981‐11986
- Marles SL, Greenberg CR, Persaud TV, Shuckett EP, Chudley AE. New familial syndrome of unilateral upper eyelid coloboma, aberrant anterior hairline pattern, and anal anomalies in Manitoba Indians. Am J Med Genet
- Yeung A, Amor D, Savarirayan R. Familial upper eyelid coloboma with ipsilateral anterior hairline abnormality: two new reports of MOTA syndrome. Am J Med Genet A. 2009;149A(4):767‐769
- Li C, Marles SL, Greenberg CR, et al. Manitoba Oculotrichoanal (MOTA) syndrome: report of eight new cases. Am J Med Genet A. 2007;143A(8):853‐857
- Slavotinek AM, Baranzini SE, Schanze D, et al. Manitoba-oculo-tricho-anal (MOTA) syndrome is caused by mutations in FREM1. J Med Genet. 2011;48(6):375‐382